← Back to Search

Other

ApoGraft for Graft-versus-Host Disease

Phase 1
Waitlist Available
Led By Zhifu Xiang, M.D.
Research Sponsored by Washington University School of Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through 1 year post-transplantation of apograft product
Awards & highlights

Study Summary

This trial is testing whether a new way to prepare stem cells for transplantation will be safe and reduce the risk of complications.

Eligible Conditions
  • Graft-versus-Host Disease
  • Hematopoietic Stem Cell Transplant

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through 1 year post-transplantation of apograft product
This trial's timeline: 3 weeks for screening, Varies for treatment, and through 1 year post-transplantation of apograft product for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Safety and tolerability of ApoGraft as measured by adverse events related to ApoGraft product
Secondary outcome measures
Cumulative incidence of graft failure
Incidence of Grade 2-4 acute GVHD
Incidence of Grade 3-4 acute GVHD
+7 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: RecipientExperimental Treatment1 Intervention
Will undergo institutionally standard myeloablative or reduced intensity chemotherapy or chemoradiotherapy which will be administered at the discretion of the treating physician Recipients will undergo a single fresh ApoGraft transplant as per standard clinical site guidelines
Group II: DonorActive Control1 Intervention
-Donors will undergo apheresis from peripheral blood after daily G-CSF administration (for up to 5 days prior to Day -1)

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

Cellect BiotechnologyIndustry Sponsor
2 Previous Clinical Trials
24 Total Patients Enrolled
Washington University School of MedicineLead Sponsor
1,945 Previous Clinical Trials
2,304,559 Total Patients Enrolled
Zhifu Xiang, M.D.Principal InvestigatorWashington University School of Medicine
~1 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top